{"title":"影响富血小板血浆和血小板衍生生长因子- bb的数量和质量的因素:一项观察性研究","authors":"R. Verma, A. Kandwal, G. Negi, H. Chandra","doi":"10.1097/JBR.0000000000000091","DOIUrl":null,"url":null,"abstract":"Abstract Objective: Platelet-rich plasma (PRP) releases growth factors upon activation, which in turn accelerates healing and regeneration of the target tissue. However, PRP composition may vary according to the patient's demographics, and wider applications of PRP warrant product standardization. The current study aimed to examine variables influencing the platelet-derived growth factor BB (PDGF-BB) concentration in PRP. Methods: This observational study was conducted in the Department of Pathology and Dentistry at Swami Rama Himalayan University, a tertiary care hospital in northern India from December 2016 to November 2017. PRP was prepared from 40 mL of whole blood from 35 individuals (22 women, 13 men). Platelet counts, platelet indices (platelet distribution width, mean platelet volume) and PDGF-BB levels were measured, and platelet yield, platelet dose, and growth factor dose in PRP were also calculated. All parameters were analyzed using Pearson's correlation coefficient. The association between PDGF-BB and PRP platelet count was evaluated using logistic regression. This study was approved by the Ethics Committee of Swami Rama Himalayan University (SRHU/HIMS/ETHICS/2016/103) on September 7, 2016. Results: The mean platelet count, PDGF-BB concentration, platelet yield, platelet dose, and growth factor dose in PRP were 1317 × 109/L, 30 ± 9.89ng/mL, 71.62 ± 28.34%, 6.5 ± 3.5 × 109, and 159.62 ± 52.39ng/mL, respectively. Linear regression analysis indicated that PRP platelet counts were a good predictor for PGDF-BB (P < 0.05; adjusted R2 = 0.96. PRP platelet count was significantly positively correlated with PDGF-BB concentration (r = 0.74, P < 0.001), platelet yield (r = 0.80, P < 0.001), platelet dose (r = 1, P < 0.001), and growth factor dose (r = 0.74, P < 0.001). Conclusions: PRP has wide clinical applications associated with its healing and regenerative properties, and both the quality and quantity of PRP thus need to be standardized as per the requirements. Evaluating variables affecting PRP will thus aid pathologists and clinical practitioners.","PeriodicalId":150904,"journal":{"name":"Journal of Bio-X Research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Factors affecting the quantity and quality of platelet-rich plasma and platelet-derived growth factor-BB: an observational study\",\"authors\":\"R. Verma, A. Kandwal, G. Negi, H. Chandra\",\"doi\":\"10.1097/JBR.0000000000000091\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract Objective: Platelet-rich plasma (PRP) releases growth factors upon activation, which in turn accelerates healing and regeneration of the target tissue. However, PRP composition may vary according to the patient's demographics, and wider applications of PRP warrant product standardization. The current study aimed to examine variables influencing the platelet-derived growth factor BB (PDGF-BB) concentration in PRP. Methods: This observational study was conducted in the Department of Pathology and Dentistry at Swami Rama Himalayan University, a tertiary care hospital in northern India from December 2016 to November 2017. PRP was prepared from 40 mL of whole blood from 35 individuals (22 women, 13 men). Platelet counts, platelet indices (platelet distribution width, mean platelet volume) and PDGF-BB levels were measured, and platelet yield, platelet dose, and growth factor dose in PRP were also calculated. All parameters were analyzed using Pearson's correlation coefficient. The association between PDGF-BB and PRP platelet count was evaluated using logistic regression. This study was approved by the Ethics Committee of Swami Rama Himalayan University (SRHU/HIMS/ETHICS/2016/103) on September 7, 2016. Results: The mean platelet count, PDGF-BB concentration, platelet yield, platelet dose, and growth factor dose in PRP were 1317 × 109/L, 30 ± 9.89ng/mL, 71.62 ± 28.34%, 6.5 ± 3.5 × 109, and 159.62 ± 52.39ng/mL, respectively. Linear regression analysis indicated that PRP platelet counts were a good predictor for PGDF-BB (P < 0.05; adjusted R2 = 0.96. PRP platelet count was significantly positively correlated with PDGF-BB concentration (r = 0.74, P < 0.001), platelet yield (r = 0.80, P < 0.001), platelet dose (r = 1, P < 0.001), and growth factor dose (r = 0.74, P < 0.001). Conclusions: PRP has wide clinical applications associated with its healing and regenerative properties, and both the quality and quantity of PRP thus need to be standardized as per the requirements. Evaluating variables affecting PRP will thus aid pathologists and clinical practitioners.\",\"PeriodicalId\":150904,\"journal\":{\"name\":\"Journal of Bio-X Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-03-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Bio-X Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/JBR.0000000000000091\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Bio-X Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/JBR.0000000000000091","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
摘要
目的:富血小板血浆(PRP)在激活后释放生长因子,从而加速靶组织的愈合和再生。然而,PRP的组成可能会根据患者的人口统计数据而变化,PRP的广泛应用保证了产品标准化。本研究旨在研究影响PRP中血小板衍生生长因子BB (PDGF-BB)浓度的变量。方法:本观察性研究于2016年12月至2017年11月在印度北部三级保健医院斯瓦米拉玛喜马拉雅大学病理和牙科学系进行。从35个人(22名女性,13名男性)的40 mL全血中制备PRP。测定血小板计数、血小板指数(血小板分布宽度、平均血小板体积)、PDGF-BB水平,计算血小板产率、血小板剂量、PRP中生长因子剂量。所有参数采用Pearson相关系数进行分析。PDGF-BB和PRP血小板计数之间的关系采用logistic回归评估。本研究于2016年9月7日获得斯瓦米·拉玛喜马拉雅大学伦理委员会(SRHU/HIMS/ Ethics /2016/103)批准。结果:PRP组平均血小板计数1317 × 109/L, PDGF-BB浓度30±9.89ng/mL,血小板产率71.62±28.34%,血小板剂量6.5±3.5 × 109,生长因子剂量159.62±52.39ng/mL。线性回归分析显示PRP血小板计数是PGDF-BB的良好预测因子(P < 0.05;调整后R2 = 0.96。PRP血小板计数与PDGF-BB浓度(r = 0.74, P < 0.001)、血小板产率(r = 0.80, P < 0.001)、血小板剂量(r = 1, P < 0.001)、生长因子剂量(r = 0.74, P < 0.001)呈正相关。结论:PRP具有良好的愈合和再生功能,具有广泛的临床应用价值,PRP的质量和数量需要按照要求进行规范。因此,评估影响PRP的变量将有助于病理学家和临床医生。
Factors affecting the quantity and quality of platelet-rich plasma and platelet-derived growth factor-BB: an observational study
Abstract Objective: Platelet-rich plasma (PRP) releases growth factors upon activation, which in turn accelerates healing and regeneration of the target tissue. However, PRP composition may vary according to the patient's demographics, and wider applications of PRP warrant product standardization. The current study aimed to examine variables influencing the platelet-derived growth factor BB (PDGF-BB) concentration in PRP. Methods: This observational study was conducted in the Department of Pathology and Dentistry at Swami Rama Himalayan University, a tertiary care hospital in northern India from December 2016 to November 2017. PRP was prepared from 40 mL of whole blood from 35 individuals (22 women, 13 men). Platelet counts, platelet indices (platelet distribution width, mean platelet volume) and PDGF-BB levels were measured, and platelet yield, platelet dose, and growth factor dose in PRP were also calculated. All parameters were analyzed using Pearson's correlation coefficient. The association between PDGF-BB and PRP platelet count was evaluated using logistic regression. This study was approved by the Ethics Committee of Swami Rama Himalayan University (SRHU/HIMS/ETHICS/2016/103) on September 7, 2016. Results: The mean platelet count, PDGF-BB concentration, platelet yield, platelet dose, and growth factor dose in PRP were 1317 × 109/L, 30 ± 9.89ng/mL, 71.62 ± 28.34%, 6.5 ± 3.5 × 109, and 159.62 ± 52.39ng/mL, respectively. Linear regression analysis indicated that PRP platelet counts were a good predictor for PGDF-BB (P < 0.05; adjusted R2 = 0.96. PRP platelet count was significantly positively correlated with PDGF-BB concentration (r = 0.74, P < 0.001), platelet yield (r = 0.80, P < 0.001), platelet dose (r = 1, P < 0.001), and growth factor dose (r = 0.74, P < 0.001). Conclusions: PRP has wide clinical applications associated with its healing and regenerative properties, and both the quality and quantity of PRP thus need to be standardized as per the requirements. Evaluating variables affecting PRP will thus aid pathologists and clinical practitioners.